PubRank

Denis Hochstrasser

Author PubWeight™ 39.49‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Functional proteomic analysis of human nucleolus. Mol Biol Cell 2002 3.07
2 Clinical proteomics: A need to define the field and to begin to set adequate standards. Proteomics Clin Appl 2007 2.84
3 The human proteome project: current state and future direction. Mol Cell Proteomics 2011 2.34
4 The Chromosome-Centric Human Proteome Project for cataloging proteins encoded in the genome. Nat Biotechnol 2012 2.14
5 Expression profiling of human immune cell subsets identifies miRNA-mRNA regulatory relationships correlated with cell type specific expression. PLoS One 2012 1.76
6 Recommendations for biomarker identification and qualification in clinical proteomics. Sci Transl Med 2010 1.59
7 CYP2E1 genotype and isoniazid-induced hepatotoxicity in patients treated for latent tuberculosis. Eur J Clin Pharmacol 2006 1.25
8 EasyProt--an easy-to-use graphical platform for proteomics data analysis. J Proteomics 2012 1.20
9 Should the Human Proteome Project be gene- or protein-centric? J Proteome Res 2008 1.15
10 How shall we use the proteomics toolbox for biomarker discovery? J Proteome Res 2007 1.11
11 Simultaneous quantification of cyclosporine, tacrolimus, sirolimus and everolimus in whole blood by liquid chromatography-electrospray mass spectrometry. Clin Biochem 2008 0.97
12 Bronchoalveolar lavage fluid protein composition in patients with sarcoidosis and idiopathic pulmonary fibrosis: a two-dimensional electrophoretic study. Electrophoresis 2002 0.97
13 Anti-apolipoprotein A-1 IgG predicts major cardiovascular events in patients with rheumatoid arthritis. Arthritis Rheum 2010 0.97
14 The human proteome project: Current state and future direction. Mol Cell Proteomics 2011 0.96
15 Industrial-scale proteomics: from liters of plasma to chemically synthesized proteins. Proteomics 2004 0.96
16 Quantitative Clinical Chemistry Proteomics (qCCP) using mass spectrometry: general characteristics and application. Clin Chem Lab Med 2013 0.91
17 Is a gene-centric human proteome project the best way for proteomics to serve biology? Proteomics 2010 0.90
18 Discovery of proteins related to coronary artery disease using industrial-scale proteomics analysis of pooled plasma. Am Heart J 2006 0.87
19 Proteomic approaches to study Staphylococcus aureus pathogenesis. J Proteomics 2009 0.87
20 Multi-dimensional HPLC/MS of the nucleolar proteome using HPLC-chip/MS. J Sep Sci 2006 0.84
21 Proteomic approach to investigate MRSA. Methods Mol Biol 2007 0.84
22 Quantification of cyclosporine and tacrolimus in whole blood. Comparison of liquid chromatography-electrospray mass spectrometry with the enzyme multiplied immunoassay technique. Clin Biochem 2008 0.81
23 Influence of ABCB1 gene polymorphisms and P-glycoprotein activity on cyclosporine pharmacokinetics in peripheral blood mononuclear cells in healthy volunteers. Drug Metab Lett 2008 0.81
24 Persistence of mild parkinsonism 4 months after liver transplantation in patients with preoperative minimal hepatic encephalopathy: a study on neuroradiological and blood manganese changes. Transpl Int 2002 0.81
25 Quantification of cyclosporine A in peripheral blood mononuclear cells by liquid chromatography-electrospray mass spectrometry using a column-switching approach. J Chromatogr B Analyt Technol Biomed Life Sci 2007 0.80
26 Evaluation of cardiovascular risk in patients with rheumatoid arthritis: do cardiovascular biomarkers offer added predictive ability over established clinical risk scores? Arthritis Care Res (Hoboken) 2012 0.80
27 Cardiac biomarkers levels predict pulmonary embolism extent on chest computed tomography and prognosis in non-massive pulmonary embolism. Thromb Haemost 2009 0.78
28 Urinary proteomics and drug discovery in chronic kidney disease: a new perspective. J Proteome Res 2010 0.77
29 [From genome to proteome--aim of human proteomics]. Seikagaku 2004 0.77
30 Wipe sampling procedure coupled to LC-MS/MS analysis for the simultaneous determination of 10 cytotoxic drugs on different surfaces. Anal Bioanal Chem 2011 0.77
31 LC-MS (/MS) in clinical toxicology screening methods. Chimia (Aarau) 2012 0.77
32 Identification of hemoglobin variants by top-down mass spectrometry using selected diagnostic product ions. Anal Bioanal Chem 2015 0.77
33 Correlation between cardiac biomarkers and right ventricular enlargement on chest CT in non massive pulmonary embolism. Thromb Res 2007 0.77
34 Extraction of amino acids by reverse iontophoresis: simulation of therapeutic monitoring in vitro. Eur J Pharm Biopharm 2008 0.76
35 Proteomic approach to investigate pathogenicity and metabolism of methicillin-resistant Staphylococcus aureus. Methods Mol Biol 2014 0.76
36 Quantitative mass spectrometry analysis of intact hemoglobin A2 by precursor ion isolation and detection. Anal Chem 2013 0.76
37 Qualitative and quantitative analysis of glycated proteins in human plasma by glucose isotopic labeling with ¹³C6-reducing sugars. Methods Mol Biol 2011 0.76
38 The magic of words. J Proteomics 2014 0.75
39 Extraction of amino acids by reverse iontophoresis in vivo. Eur J Pharm Biopharm 2009 0.75
40 Current role of liquid chromatography coupled to mass spectrometry in clinical toxicology screening methods. Clin Chem Lab Med 2011 0.75
41 Translational proteomics. J Proteomics 2012 0.75
42 The 9th Siena Meeting - from genome to proteome: open innovations. J Proteomics 2013 0.75
43 Mass spectrometry in laboratory medicine. Clin Chem Lab Med 2003 0.75
44 Detection of biomarkers of stroke using SELDI-TOF. Methods Mol Biol 2007 0.75